PharmaVoice 100: Page 4

  • A portrait of Nello Mainolfi framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Nello Mainolfi
    Image attribution tooltip
    Profile // PharmaVoice 100

    Entrepreneurs: Nello Mainolfi

    Kymera Therapeutics’ CEO is chasing untreated disease targets by advancing a game-changing technology.

    By PharmaVoice staff • Sept. 6, 2022
  • A portrait of Nina Wachsman framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Nina Wachsman
    Image attribution tooltip
    Profile // PharmaVoice 100

    Entrepreneurs: Nina Wachsman

    The CEO and co-founder of Know Rare is on a mission to connect rare disease patients with researchers and clinical trials.

    By PharmaVoice staff • Sept. 6, 2022
  • A portrait of Otis Johnson framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Otis Johnson
    Image attribution tooltip
    Profile // PharmaVoice 100

    DE&I Champions: Otis Johnson

    Clario’s chief diversity, inclusion and sustainability officer is looking to improve clinical trial recruitment with a bottom-up approach that first focuses on internal hiring practices. 

    By Karissa Waddick • Sept. 6, 2022
  • A portrait of Dr. Penelope Manasco framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Penelope Manasco
    Image attribution tooltip
    Profile // PharmaVoice 100

    Entrepreneurs: Dr. Penelope Manasco

    How the NIH-trained scientist and CEO of MANA RBM is charting a new way forward in conducting clinical trials.

    By Alexandra Pecci • Sept. 6, 2022
  • A portrait of Rafael Amado framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Rafael Amado
    Image attribution tooltip
    Profile // PharmaVoice 100

    Innovators: Dr. Rafael Amado

    Quiet, supportive and collaborative leadership have made the R&D leader a standout innovator for Allogene Therapeutics.

    By Alexandra Pecci • Sept. 6, 2022
  • A portrait of Rahul Ballal framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Rahul Ballal
    Image attribution tooltip
    Profile // PharmaVoice 100

    Legacy Leaders: Rahul Ballal

    Imara’s CEO walks the walk when it comes to being a patient-first company by empowering his teams to lead important initiatives with far-ranging impact.

    By PharmaVoice staff • Sept. 6, 2022
  • A portrait of Raymond Stevens framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Raymond Stevens
    Image attribution tooltip
    Profile // PharmaVoice 100

    Legacy Leaders: Raymond Stevens

    The longtime pioneer in new drug discovery methods and founder of Structure Therapeutics has leveraged innovative science for commercial success.

    By • Sept. 6, 2022
  • A portrait of Renata Campos framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Renata Campos
    Image attribution tooltip
    Profile // PharmaVoice 100

    DE&I Champions: Renata Campos

    Takeda's Growth and Emerging Markets Business Unit president is driving growth by doing what’s right for patients and her teams.

    By PharmaVoice staff • Sept. 6, 2022
  • A portrait of Dr. Rich Christie framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Dr. Rich Christie
    Image attribution tooltip
    Profile // PharmaVoice 100

    Tech Wizards: Dr. Rich Christie

    Driven by an enthusiasm for invention and a connection between scientific expertise and patient outcomes, the AiCure chief medical officer looks to nurture AI-powered technology.

    By PharmaVoice staff • Sept. 6, 2022
  • A portrait of Rosalind Brewer framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Rosalind Brewer
    Image attribution tooltip
    Profile // PharmaVoice 100

    Disrupters: Rosalind Brewer

    The CEO of Walgreens Boots Alliance is transforming the pharmacy powerhouse into a major new player in the healthcare space.

    By PharmaVoice staff • Sept. 6, 2022
  • A portrait of Sally Allain framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Sally Allain
    Image attribution tooltip
    Profile // PharmaVoice 100

    Disrupters: Sally Allain

    The newest location for Johnson & Johnson Innovation’s incubator JLABS is in Washington, D.C., and the head of the cutting-edge space is bringing a diverse set of disruptive companies together.

    By Michael Gibney • Sept. 6, 2022
  • A portrait of Samantha Singer framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Samantha Singer
    Image attribution tooltip
    Profile // PharmaVoice 100

    Disrupters: Samantha Singer

    Abata’s CEO is stepping into the ring to fight for patients with progressive MS and other autoimmune disorders.

    By PharmaVoice staff • Sept. 6, 2022
  • A portrait of Sarah Hersey framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Sarah Hersey
    Image attribution tooltip
    Profile // PharmaVoice 100

    Innovators: Sarah Hersey

    At Bristol Myers Squibb, Sarah Hersey challenges the norm — and herself — to continually bring the best solutions to patients as vice president of translational sciences and diagnostics.

    By Alexandra Pecci • Sept. 6, 2022
  • A portrait of Sastry Chilukuri framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Sastry Chilukuri
    Image attribution tooltip
    Profile // PharmaVoice 100

    Tech Wizards: Sastry Chilukuri

    The co-CEO of Medidata is ushering in the next generation of clinical trial advancements, making research easier and more patient-focused than ever before.

    By PharmaVoice staff • Sept. 6, 2022
  • A portrait of Scott Gray framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Scott Gray
    Image attribution tooltip
    Profile // PharmaVoice 100

    DE&I Champions: Scott Gray

    The CEO, founder and president of Clincierge is championing diversity and inclusion within the company and beyond.

    By • Sept. 6, 2022
  • A portrait of Sebastian Guth framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Sebastian Guth
    Image attribution tooltip
    Profile // PharmaVoice 100

    DE&I Champions: Sebastian Guth

    Bayer Pharmaceuticals’ president, Americas Region, is driving equality efforts both within the company and for patients.

    By PharmaVoice staff • Sept. 6, 2022
  • A portrait of Shanthi Ganeshan framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Shanthi Ganeshan
    Image attribution tooltip
    Profile // PharmaVoice 100

    Innovators: Shanthi Ganeshan

    The longtime regulatory pro has used innovative strategies to deliver emerging oncology therapies to patients from her position as head of regulatory affairs at Stemline.

    By • Sept. 6, 2022
  • A portrait of Simba Gill framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Simba Gill
    Image attribution tooltip
    Profile // PharmaVoice 100

    Disrupters: Simba Gill

    The CEO of Evelo Biosciences is going where no one else in biotech has gone before.

    By • Sept. 6, 2022
  • A portrait of Dr. Stephen Dale framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Dr. Stephen Dale
    Image attribution tooltip
    Profile // PharmaVoice 100

    Innovators: Dr. Stephen Dale

    The CMO at Kura Oncology, a clinical-stage biopharma company, is charting a new course to deliver on the promise of precision medicine in oncology.

    By PharmaVoice staff • Sept. 6, 2022
  • A portrait of Dr. Steven Steinhubl framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Dr. Steven Steinhubl
    Image attribution tooltip
    Profile // PharmaVoice 100

    Legacy Leaders: Dr. Steven Steinhubl

    The chief medical officer at physIQ is working at the intersection of healthcare, clinical trials and technology to deliver better, faster and more accurate treatments to patients around the globe.

    By Karissa Waddick • Sept. 6, 2022
  • A portrait of Dr. Tania Small framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Dr. Tania Small
    Image attribution tooltip
    Profile // PharmaVoice 100

    Disrupters: Dr. Tania Small

    GSK’s medical oncology head is paving the way for patient-driven drug development and more equitable care.

    By PharmaVoice staff • Sept. 6, 2022
  • A portrait of Trishna Bharadia framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Trishna Bharadia
    Image attribution tooltip
    Profile // PharmaVoice 100

    Disrupters: Trishna Bharadia

    As a patient advocate, The Spark Global’s owner is transforming how pharma companies approach patient centricity.

    By Alexandra Pecci • Sept. 6, 2022
  • A portrait of Vincent Keunen framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Vincent Keunen
    Image attribution tooltip
    Profile // PharmaVoice 100

    Entrepreneurs: Vincent Keunen

    With his unique platform, the  has built a bridge between patients, physicians and researchers around the world.  

    By • Sept. 6, 2022
  • A portrait of WeiQing Zhou framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by WeiQing Zhou
    Image attribution tooltip
    Profile // PharmaVoice 100

    Entrepreneurs: WeiQing Zhou

    The COO has launched two jewels in the biotech world that complement each other while serving broader innovation goals throughout the industry. 

    By • Sept. 6, 2022
  • A portrait of Dr. Yvonne Greenstreet framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Yvonne Greenstreet
    Image attribution tooltip
    Profile // PharmaVoice 100

    Disrupters: Dr. Yvonne Greenstreet

    The CEO of Alnylam — a leader in RNAi therapies — has the company at the top of its game scientifically and culturally.

    By PharmaVoice staff • Sept. 6, 2022